<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-2.anc" start="12336" end="12341" sStart="12206" offset="130" sid="r7.1.use.v.0216" wn="1" wnkey="use%2:34:01::" annotator="cgozo" text="However, tumors from Wnt-1 TG, Pten +/+ mice have low apoptotic rates (40 ± 16 per digital camera field using a 20x objective) and high proliferation rates (53% ± 11)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-2.anc" start="10370" end="10380" sStart="null" offset="4" sid="r8.suggest.v.0257" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="4), suggesting that Pten was, indeed, made from the second allele." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-2.anc" start="9688" end="9698" sStart="null" offset="4" sid="r8.suggest.v.0181" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="3), suggesting a more aggressive phenotype." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2199-2-2.anc" start="19100" end="19109" sStart="null" offset="74" sid="r8.suggest.v.0703" wn="3" wnkey="suggest%2:32:02::" annotator="brubin" text="One such candidate is the rapamycin analog CCI779, which has been suggested to inhibit the AKT signaling pathway, probably through inhibition of mTOR (target of rapamycin), a potential target of AKT [reviewed in ref." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="veweser" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="veweser" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="jeneale" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="brubin" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="a4" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="a3" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="a2" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2199-2-2.anc" start="15202" end="15206" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" annotator="a1" text="The majority of tumors in Wnt-1 TG, Pten +/- mice had &lt;b&gt;lost&lt;/b&gt; the wild type allele of Pten , suggesting that the complete inactivation of Pten function provides an additional growth advantage to these tumors." />
  </sentences>
</list>